实用肿瘤学杂志
實用腫瘤學雜誌
실용종류학잡지
JOURNAL OF PRACTICAL ONCOLOGY
2013年
6期
554-558
,共5页
吕达(综述)%乔文波(审校)
呂達(綜述)%喬文波(審校)
려체(종술)%교문파(심교)
放射性肺损伤%细胞因子%基因多态性%基质金属蛋白酶%治疗
放射性肺損傷%細胞因子%基因多態性%基質金屬蛋白酶%治療
방사성폐손상%세포인자%기인다태성%기질금속단백매%치료
Radiation-induced lung injury%Cytokine%Single nucleotide polymorphism%Matrix metallo-proteinase%Therapy
胸部肿瘤治疗过程中大约2/3的患者需要放射治疗,治疗期间正常肺组织不可避免接受一定量的放射线照射,由此导致胸部肿瘤放疗中最常出现的并发症:放射性肺损伤( Radiation-induced lung injury,RILI),通常放射学改变比临床表现更为常见。 RILI已成为制约提高肿瘤放疗疗效的瓶颈。目前尚无准确可靠的方法能够预测RILI的发生,RILI一旦发生后病情不可逆转,治疗手段近几十年来也一直处于停滞阶段,下面将现在已知的RILI预测因子与治疗手段及未来新的研究思路做一综述。
胸部腫瘤治療過程中大約2/3的患者需要放射治療,治療期間正常肺組織不可避免接受一定量的放射線照射,由此導緻胸部腫瘤放療中最常齣現的併髮癥:放射性肺損傷( Radiation-induced lung injury,RILI),通常放射學改變比臨床錶現更為常見。 RILI已成為製約提高腫瘤放療療效的瓶頸。目前尚無準確可靠的方法能夠預測RILI的髮生,RILI一旦髮生後病情不可逆轉,治療手段近幾十年來也一直處于停滯階段,下麵將現在已知的RILI預測因子與治療手段及未來新的研究思路做一綜述。
흉부종류치료과정중대약2/3적환자수요방사치료,치료기간정상폐조직불가피면접수일정량적방사선조사,유차도치흉부종류방료중최상출현적병발증:방사성폐손상( Radiation-induced lung injury,RILI),통상방사학개변비림상표현경위상견。 RILI이성위제약제고종류방료료효적병경。목전상무준학가고적방법능구예측RILI적발생,RILI일단발생후병정불가역전,치료수단근궤십년래야일직처우정체계단,하면장현재이지적RILI예측인자여치료수단급미래신적연구사로주일종술。
About 2/3 patients with chest tumor requires radiation therapy .Normal lung tissues inevitably receive a certain amount of radiation during the treatment ,which results in the most frequent complication in tho-racic tumor radiotherapy:radiation-induced lung injury(radiation-induced lung injury,RILI).Usually,radio-logical changes are more common than clinical manifestations .RILI has become the bottleneck in radiotherapy which restricts the improvement of efficacy .At present ,there is no accurate and reliable method to predict the oc-currence of RILI .Once RILI occurs ,the condition is irreversible and treatment in recent decades has been stag-nant.In the present review ,we summarized the RILI predictors and RILI treatment methods .